Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -22.94
- Piotroski Score 2.00
- Grade Buy
- Symbol (SQZ)
- Company SQZ Biotechnologies Company
- Price $0.44
- Changes Percentage (61.11%)
- Change $0.17
- Day Low $0.38
- Day High $0.57
- Year High $3.56
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with other immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/02/2023
- Fiscal Year End N/A
- Average Stock Price Target $400.00
- High Stock Price Target $400.00
- Low Stock Price Target $400.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.16
- Trailing P/E Ratio -0.20138888888889
- Forward P/E Ratio -0.20138888888889
- P/E Growth -0.20138888888889
- Net Income $-78,244,000
Income Statement
Quarterly
Annual
Latest News of SQZ
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Serica Energy (LON:SQZ) Is Very Good At Capital Allocation
To identify a stock with long-term growth potential, focus on increasing Return on Capital Employed (ROCE) and expanding capital employed. Serica Energy (LON:SQZ) shows promising ROCE of 29%, surpassi...
By Yahoo! Finance | 4 months ago
